Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Misclassification of Bronchioloalveolar Carcinoma with Cytologic Diagnosis of Lung Cancer

Misclassification of Bronchioloalveolar Carcinoma with Cytologic Diagnosis of Lung Cancer Diagnosis of NSCLC by cytology alone results in significant misclassification of BAC, most commonly as adenocarcinoma or undifferentiated NSCLC. Because patients with BAC respond differently to certain treatments such as endothelial growth factor receptor inhibitors and surgical resection of multifocal lung cancer, misclassification of BAC may have important therapeutic implications. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Thoracic Oncology Wolters Kluwer Health

Misclassification of Bronchioloalveolar Carcinoma with Cytologic Diagnosis of Lung Cancer

Jablons, David M.
Journal of Thoracic Oncology , Volume 1 (9) – Nov 1, 2006
Download PDF
6 pages

Loading next page...
 
/lp/wolters-kluwer-health/misclassification-of-bronchioloalveolar-carcinoma-with-cytologic-7OLpSMQW8A

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
1556-0864

Abstract

Diagnosis of NSCLC by cytology alone results in significant misclassification of BAC, most commonly as adenocarcinoma or undifferentiated NSCLC. Because patients with BAC respond differently to certain treatments such as endothelial growth factor receptor inhibitors and surgical resection of multifocal lung cancer, misclassification of BAC may have important therapeutic implications.

Journal

Journal of Thoracic Oncology – Wolters Kluwer Health

Published: Nov 1, 2006

There are no references for this article.